Dana Solutions part of HESI U01 award from the FDA to study cardiac failure modes
Subaward to Dana Solutions will support the application of Artificial Intelligence for cardiac drug safety testing PALO ALTO, CALIF. (PRWEB) JULY 22, 2019 Dana Solutions announced today that it will receive a subaward from the Health and Environmental Sciences Institute (HESI) as part of a multi-year U01 grant from the FDA.[…]
Read more